HEREDITARY ANGIOEDEMA TYPE II
Clinical trials for HEREDITARY ANGIOEDEMA TYPE II explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA TYPE II trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop swelling attacks in hereditary angioedema
Disease control Recruiting nowThis phase 3 study tests an intravenous C1 esterase inhibitor (C1-INH) in people with hereditary angioedema (HAE) to treat acute attacks and prevent attacks before medical procedures. About 124 participants, aged 2 and older, will receive either the drug or a placebo. The main go…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE II
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with rare swelling disorder as drug trial begins
Disease control Recruiting nowThis study tests a drug called donidalorsen in 20 children aged 2 to 12 with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. The goal is to see if the drug is safe and how it works in young bodies. Researchers will monitor side effects and measure h…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE II
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC